Is botulinum toxin type A more effective and safer than other treatments for the management of lower limb spasticity in children with cerebral palsy? A Cochrane Review summary with commentary.
BACKGROUND: Botulinum toxin A (BoNT-A) is a well-accepted treatment for the medical management of spasticity in children with cerebral palsy (CP). OBJECTIVE: To assess the efficacy and safety of BoNT-A compared with other treatment options in managing lower limb spasticity in children with CP. METHO...
| Publicado en: | NeuroRehabilitation Vol. 49; no. 1; pp. 161 - 165 |
|---|---|
| Autores principales: | , |
| Formato: | commentary Journal Article |
| Publicado: |
Sage Publications Inc.
2021
|
| Acceso en línea: | Ver este registro en EBSCOhost |